Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 22:3:142.
doi: 10.3389/fbioe.2015.00142. eCollection 2015.

The Golden Age in Cancer Nanobiotechnology: Quo Vadis?

Affiliations

The Golden Age in Cancer Nanobiotechnology: Quo Vadis?

João Conde. Front Bioeng Biotechnol. .
No abstract available

Keywords: cancer nanotechnology; clinical trials as topic; in vivo models; medical devices; nanobiotechnology; nanomedicine; translational medical research.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The golden age in cancer nanobiotechnology: promises and pitfalls. After a decade of substantial investment around the world, we are often asked what nano can do beyond discovering new systems and methods to produce novel materials? Although all studies described so far provide a baseline level of data in support of the effectiveness and safety of nanomaterials, we wonder what have we learned so far? Which new tools lead to new Nanoscience? Where are the commercial products on Nanotechnology? Is nanotechnology truly the next trillion-dollar market?

References

    1. Albanese A., Tang P. S., Chan W. C. W. (2012). The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 14, 1–16.10.1146/annurev-bioeng-071811-150124 - DOI - PubMed
    1. Anker J. N., Hall W. P., Lyandres O., Shah N. C., Zhao J., Van Duyne R. P. (2008). Biosensing with plasmonic nanosensors. Nat. Mater. 7, 442–453.10.1038/nmat2162 - DOI - PubMed
    1. Cao Y. C., Jin R., Thaxton C. S., Mirkin C. A. (2005). A two-color-change, nanoparticle-based method for DNA detection. Talanta 67, 449–455.10.1016/j.talanta.2005.06.063 - DOI - PubMed
    1. Conde J., Artzi N. (2015). Are RNAi and miRNA therapeutics truly dead? Trends Biotechnol. 33, 141–144.10.1016/j.tibtech.2014.12.005 - DOI - PubMed
    1. Conde J., de la Fuente J. M., Baptista P. V. (2010). RNA quantification using gold nanoprobes – application to cancer diagnostics. J. Nanobiotechnology 8, 5.10.1186/1477-3155-8-5 - DOI - PMC - PubMed

LinkOut - more resources